Could the rapid growth of GLP-1 medicines be creating an unexpected opportunity for organic and plant-based food businesses?
It’s a question that seem likely to come up at a specially convened discussion at the Danish Embassy in London next month, at which Danish and British experts who will explore how weight-loss medicines are reshaping the future of food.
The event, hosted by the Danish Agriculture & Food Council, takes place on October 20 front of an invited audience.
The session will be chaired by sustainable food consultant Simon Wright. He says: “I am really looking forward to hearing our panelists and invited audience discussing the significance of widespread GLP – one adoption. Crucially we will be identifying who wins and who loses from from this industry-wide change.”
The event will examine how changing consumer behaviour is creating opportunities for food manufacturers, retailers and the out-of-home sector. Recent UK research indicates that GLP-1 users are becoming more selective and intentional in their food choices. Smaller appetites, faster fullness and changing sensory preferences increase demand for foods that deliver nourishment, digestibility and satisfaction in smaller portions.
The discussion will be initiated by short presentations from Lotte Bjerre Knudsen , the pioneering scientist who led the invention of the first long -acting GLP -1 medicine; Andrew Wardlaw , Chief Ideas Officer at MMR Research; Chris Mitchell , Co -founder of Bramble Partners; and Anders Nicolajsen , Head of Foodservice & Gastronomy at the Danish Agriculture & Food Council.
For the food industry, the implications extend far beyond consumers simply eating less. GLP-1 medicines may accelerate a broader shift towards nutrient-dense products, smaller but more purposeful portions, high-quality ingredients and foods that offer greater value in every bite. This creates opportunities for agile manufacturers and foodservice operators, including the organic and plant -based sectors, to develop products that combine nutrition, enjoyment and convenience without appearing clinical or restrictive.
“GLP-1 (could be) one of the most interesting change agents in food culture in many years — creating new opportunities for organic, plant-rich and nutrient-dense foods”
Commenting, Anders Nicolajsen, Head of Gastronomy & Foodservice, Danish Agriculture & Food Council, said: “The future plate may be smaller. But there is no reason it should be less exciting. Quite the opposite. As GLP-1 medicinesnencourage people to eat less, every bite has the potential to matter more. The future will not necessarily be about eating less food — but about getting more from the food we eat. GLP-1 may make millions of people pause and rethink their relationship with food: what they eat, why they eat it, how it’s produced and what gives a meal meaning. That could make GLP-1 one of the most interesting change agents in food culture in many years — creating new opportunities for organic, plant-rich and nutrient-dense foods that deliver flavour, nourishment and satisfaction in smaller portions.”
The event forms part of a wider Danish initiative to promote organic and plant-based food solutions in the UK and encourage dialogue between British and Danish stakeholders on the future of food.
